Protection by Vaccines and Previous Infection Against the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 (vol 226, pg 1385, 2022)

被引：0
|
作者：
Smid
机构：
来源：
JOURNAL OF INFECTIOUS DISEASES | 2023年 / 227卷 / 08期
关键词：
D O I：
10.1093/infdis/jiac429
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1021 / 1022
页数：2
相关论文
共 50 条
  • [21] Plant-based vaccines: Potentiality against severe acute respiratory syndrome coronavirus 2
    Sharma, Pramita
    Mondal, Himel
    Mondal, Shaikat
    Majumder, Rabindranath
    [J]. BIOMEDICAL AND BIOTECHNOLOGY RESEARCH JOURNAL, 2021, 5 (04): : 366 - 373
  • [22] Smell and taste dysfunction in patients infected with the Omicron variant of severe acute respiratory syndrome coronavirus-2
    Chen, Yanping
    Geng, Yan
    Jiang, Juan
    Xiong, Gaoyun
    Lei, Chenyang
    [J]. ACTA OTO-LARYNGOLOGICA, 2023, 143 (06) : 489 - 494
  • [23] Description of Hospitalizations due to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Based on Vaccination Status
    Moffa, Matthew A.
    Shively, Nathan R.
    Carr, Dustin R.
    Bremmer, Derek N.
    Buchanan, Carley
    Trienski, Tamara L.
    Jacobs, Max W.
    Saini, Vikram
    Walsh, Thomas L.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (09):
  • [24] Protection Against Severe Clinical Outcomes With Adenovirus or Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Patients Hospitalized With Coronavirus Disease 2019
    Llibre, Josep M.
    Revollo, Boris
    Aguilar, Sergi
    Calomarde-Gomez, Cristina
    Bruguera, Andreu
    Martin-Iguacel, Raquel
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (05): : 938 - 940
  • [25] Evaluating Vaccine Efficacy Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection
    Lin, Dan-Yu
    Gu, Yu
    Zeng, Donglin
    Janes, Holly E.
    Gilbert, Peter B.
    [J]. CLINICAL INFECTIOUS DISEASES, 2022, 74 (03) : 544 - 552
  • [26] Respiratory management in severe acute respiratory syndrome coronavirus 2 infection
    Price, Susanna
    Singh, Suveer
    Ledot, Stephane
    Bianchi, Paolo
    Hind, Matthew
    Tavazzi, Guido
    Vranckx, Pascal
    [J]. EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2020, 9 (03) : 229 - 238
  • [27] More Analyses are Needed to Evaluate the Effectiveness of Protection by Vaccines and Previous Infection Against the Omicron Variant of SARS-CoV-2
    Vencalek, Ondrej
    Beran, Jiri
    Furst, Tomas
    Kratka, Zuzana
    Komarek, Arnost
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (05): : 942 - 943
  • [28] Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022
    Hoeve, Christina E.
    de Gier, Brechje
    Huiberts, Anne J.
    de Melker, Hester E.
    Hahne, Susan J. M.
    van den Hof, Susan
    Knol, Mirjam J.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2023, 228 (04): : 431 - 438
  • [29] Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Natural Immunity and Protection Against the Delta Variant: A Retrospective Cohort Study
    Kim, Priscilla
    Gordon, Steven M.
    Sheehan, Megan M.
    Rothberg, Michael B.
    [J]. CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E185 - E190
  • [30] Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019 (vol 26, pg 1, 2022)
    Guisado-Vasco, P.
    Gorines, J. Aguareles
    Gonzalez, M. M. Carralon
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2023, 227 (08): : 1023 - 1023
12345